Study Summary
The purpose of this study is to evaluate the safety and efficacy of CAR T cell treatment targeting TRBC1 in patients with relapsed or refractory TRBC1 positive T-cell hematological maliganacies
Want to learn more about this trial?
Request More InfoInterventions
anti-TRBC1 CAR-T cell therapyDRUG
TRBC1 positve patients with relapsed or refractory T cell malignacy will receive CAR-T cell therapy targetting TRBC1
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Xianmin Song | Shanghai | Shanghai Municipality | China |